GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
last added cars
2022-05-30|

The Global Fight Against Monkeypox: Zelixir Biotech Predicts Monkeypox Protein Structures

by GeneOnline
Share To

Abstract: China’s biotech company Zelixir Biotech publishes 600+ protein structure predictions for the Monkeypox proteome

SHANGHAI, May 30, 2022 /PRNewswire/ — Zelixir Biotech announces it has predicted more than 600 structures and added functional annotations of proteins from monkeypox virus proteomes amid the recent emergence of monkeypox cases in Europe and the United States. The predicted structures are expected to help experts worldwide to develop structure-based drug design and monkeypox vaccines.

The predicted protein structures are AI-generated by AlphaFold2-Batch (originated from the DeepMind AlphaFold2, ), the company’s self-developed  MPI-based structure prediction pipeline with heterogeneous parallelism powered by supercomputing infrastructures. The predictions are based on the complete sequence of the genome of the epidemic strain in May 2022 (ID: ON563414.2) (Ref. 1) , the whole proteome of the 2018 West African (WA) virus strain (Monkeypox virus isolate MPXV-UK_P3, ID: MT903345.1) (Ref.2), and the whole proteome of the 1996 Congo basin (CB) virus strain (Monkeypox virus strain Zaire-96-I-16, ID: NC_003310) (Ref. 3).

AlphaFold2-Batch, which is available on the company’s platform “ZCloud”, has largely boosted both the efficiency and the precision of the predictions by nearly two orders of magnitude acceleration compared to the original AlphaFold2 pipeline, generating results without any compromise of accuracies.

The precision of the AI-generated result is also supported by profound and up-to-date research by Zelixir. The published results provide functional annotations and analyses of the proteome from the latest west African strain compared with its counterpart, the 1996 Congo Basin strain.

Using the PointSite Algorithm developed by the Zelixir, the team provides profound annotations for all the 600+ predicted structures and managed to label the small molecules binding regions with high confidence for the three-dimensional structure of each protein. Meanwhile, experimentally solved structures with high similarity to monkeypox proteins are vetted through the company’s structure-alignment algorithm against a subset of Protein Data Bank database (PDB70).

Figure 1. Predicted structure of Monkeypox Virus Congo Strain: Virus termination factor large subunit (Q3I8R6); Figure 2. PointSite Prediction; Figure 3. Structure-blast Prediction

All the detailed forecasts and the corresponding functional predictions are available on its website (https://www.zelixir.com/Monkeypox/index.html).  

“We hope our work can accelerate the development of monkeypox vaccines and drug discovery. We will keep updating and publishing our new research findings as our research progresses.” said Dr. Sheng Wang, the CEO of Zelixir Biotech.

 
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
2025-01-10
United Imaging Announces Major Expansion of U.S. Manufacturing Space
2025-01-09
Complete Genomics announces mpox virus amplicon sequencing panel at AMP
2024-11-20
LATEST
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States
2025-02-13
NASA Says There’s a 1 in 43 Chance an Asteroid 2024 YR4 Could Hit Earth in 2032—Should We Worry?
2025-02-13
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
2025-02-12
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
GLP-1 Weight Loss Drugs Might Cause Blindness
2025-02-11
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-04
MIXiii Health-Tech.IL
Jerusalem, Israel
2025-03-05
Medical Japan
Osaka, Japan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
Scroll to Top